Solutions
Neurosurgeon operating with intraoperative brain imaging
Neurosurgery
Functional brain-network data for complex neurosurgical decisions.
Clinician reviewing brain imaging on a monitor
Neurology
Objective brain function insights for more informed neurological care.
Older couple walking outdoors
Brain Health
Supporting healthier brains through earlier insight.
Clinicians reviewing a brain scan on a monitor
Clinical Research
Empowering the next generation of neuroscience research.
TechnologyResourcesQuantalX NeuroscienceReimbursementAboutContact us
QuantalX Neuroscience
All resources
Peer-reviewed publication
Parkinsonism & Related Disorders
2025

TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome

Lassman S, Zifman N, Fogel H, Hassin-Baer S, Anis S

Parkinsonism and Related Disorders journal cover
Key finding

TMS-evoked potential patterns from motor, prefrontal and visual cortex stimulation were associated with tic severity and with comorbid symptoms in adults with Tourette syndrome.

Study design
Case-control study, TMS-EEG
Participants
33 adults with Tourette syndrome and 18 healthy controls

Summary

Gilles de la Tourette syndrome (TS) is a neuropsychiatric disorder linked to abnormal activity in cortico-striatal-thalamo-cortical circuits and the dopaminergic system. This study measured TMS-evoked potentials (TEPs) from selected networks to examine changes in cortical excitation and inhibition in adults with TS.

Study design

  • Participants: 33 adults with TS and 18 healthy controls.
  • Symptom severity was rated with the YGTSS (tics), PUTS (premonitory urge), Y-BOCS (OCD), CAARS (ADHD), BDI (depression) and BAI (anxiety).
  • TEPs were recorded after stimulation of the primary motor cortex (M1), dorsolateral prefrontal cortex (DLPFC) and primary visual cortex (V1).

Key findings

  • Patients with TS showed a delayed P180 latency in M1 compared with controls (p = 0.006).
  • A lower early TEP amplitude after DLPFC stimulation (50–70 ms) and a delayed DLPFC P180 latency were associated with higher tic severity (p = 0.001 and p = 0.003).
  • Early M1 amplitude (50–70 ms) differentiated patients with mild to moderate tics from those with severe tics (p = 0.003).
  • Early V1 amplitude (15–45 ms) correlated with the severity of anxiety.

Authors' conclusions

The authors suggest that distinct TEP patterns after DLPFC, M1 and V1 stimulation may shed light on the pathophysiology of TS, and that these patterns are associated with tic severity and comorbidities.

Read the full article

Lassman S, Zifman N, Fogel H, Hassin-Baer S, Anis S. TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome. Parkinsonism & Related Disorders. 2025;130:107217. doi:10.1016/j.parkreldis.2024.107217

Summary prepared by QuantalX from the published abstract. All results are as reported by the authors. The full text is available from the publisher.

Bring brain function data into your practice

Talk to the QuantalX team about Delphi-MD™ in your clinical setting.

Request a demo
On this page
Section
Journal
Parkinsonism & Related Disorders
Year
2025
DOI
10.1016/j.parkreldis.2024.107217
Licence
Copyright Elsevier. Summary by QuantalX
Read in the journal
QuantalX Neuroscience
Join our newsletter to stay up to date on clinical updates and company news.
By subscribing you agree to our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Solutions
NeurosurgeryNeurologyBrain HealthClinical ResearchPsychiatry
Company
TechnologyPartner ZoneResourcesAbout UsContact
Follow us
Facebook
Instagram
X
LinkedIn
© 2026 Quantalx. All rights reserved.
Privacy PolicyTerms of Service
*All clinical interpretations of Delphi-MD™ assessments must be made by qualified healthcare professionals within the context of a full patient evaluation. The Delphi-MD™ system is intended to elicit, record, and analyze TMS-evoked brain potentials (TEPs) and provide quantitative output parameters compared against a normative reference database limited to ages 50–75. Adverse events during or after evaluation may include headache, nausea, dizziness, fatigue, insomnia, anxiety/agitation, back or neck pain, vomiting, tinnitus, migraine aura, and abnormal sensations. Delphi-MD™ is not intended to be relied upon solely to make or confirm a diagnosis. For more information, refer to the Delphi-MD™ user manual.
Schedule a Demo